Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research

Current Issue

May 2025 (Vol. 45 Issue 5) Table of Contents
Anticancer Research: 45 (5)

Issue highlights

  • Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Reduces Aggressiveness of Cervical Carcinoma Cells
  • Long-term Outcomes of Helical Tomotherapy in Lymph Node-positive Breast Cancer Following Breast-conserving Surgery
  • Ubiquitin-proteasome Pathway-linked Gene Signatures as Prognostic Indicators in Prostate Cancer
  • Role of Stromal CD25+/CD8+ Lymphocyte Ratio in Patients With Grade 2-3 Cervical Intraepithelial Neoplasia (CIN 2-3): A Retrospective Single-center Study
  • Advantages and Disadvantages of Drug Combination Treatment: Riluzole, Metformin and Dexamethasone Effect on Glioblastoma Cell

 


 

Two Special Issues are coming in 2025:

  1. New Anticancer Agents – 2025 (Submission deadline: May 10, 2025; Publication date: July 2025). ​Click here for more information.
  2. Advances in Renal Cell Carcinoma Diagnosis and Treatment – 2025 (Submission deadline: July 10, 2025; Publication date: October 2025). ​Click here for more information.
 

Featured Articles

  • Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model of Soft-tissue Sarcoma More Closely...
    February 09, 2015
  • Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and...
    September 25, 2015
  • The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in...
    December 31, 2019
  • Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a...
    December 30, 2014
  • Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-...
    December 30, 2014
  • A Long Noncoding RNA, lncRNA-ATB, Is Involved in the Progression and Prognosis of Colorectal Cancer
    March 06, 2015

Latest Articles

  • You have access
    High Expression of OR1F1 Protein as a Potential Prognostic Biomarker for Esophageal Squamous Cell Carcinoma
    SHUNSUKE YAMAGISHI, MITSURO KANDA, TAKAHIRO SHINOZUKA, YUSUKE SATO, DAI SHIMIZU, CHIE TANAKA, SHINICHI UMEDA, HARUYOSHI TANAKA, HIDEKI TAKAMI, NORIFUMI HATTORI, MASAMICHI HAYASHI, GORO NAKAYAMA, YASUHIRO KODERA and YUKIYASU OKAMURA
    Anticancer Research May 2025, 45 (5) 1997-2009; DOI: https://doi.org/10.21873/anticanres.17575
  • Open Access
    Contribution of Methylenetetrahydrofolate Reductase Genotypes to Brain Tumor Risk Determination in Taiwan
    CHAO-HSUAN CHEN, CHUN-CHUNG CHEN, XIAN-XIU CHEN, WEN-SHIN CHANG, CHIA-WEN TSAI, MEI-CHIN MONG, SHIH-WEI HSU and DA-TIAN BAU
    Anticancer Research May 2025, 45 (5) 1861-1870; DOI: https://doi.org/10.21873/anticanres.17565
  • Open Access
    Sex-related Survival Differences in Patients With Glioblastoma – Results From a Retrospective Analysis
    JAN LEPPERT, CLAUDIA DITZ, JAKOB MATSCHKE, HARALD KRENZLIN, NAUREEN KERIC, CHRISTIAN ZIEMANN, LORENZ HAHN, MARIA VITTORIA MATONE, LARYSA LIUBICH, KAROLIN STREUBEL, HANNES SCHACHT, CHRISTINA HILLBRICHT, PATRICK KUPPLER, DIRK RADES and ANASTASSIA LÖSER
    Anticancer Research May 2025, 45 (5) 2059-2069; DOI: https://doi.org/10.21873/anticanres.17580
  • You have access
    Potential Role of PTEN and AKT/PKB Proteins in the Pathogenesis of Ovarian Mature Teratomas
    JAROSŁAW BAL, LUKASZ FULAWKA, MARIAN GABRYŚ, MAREK MURAWSKI and AGNIESZKA HALON
    Anticancer Research May 2025, 45 (5) 1843-1851; DOI: https://doi.org/10.21873/anticanres.17563
  • You have access
    The Long-term Outcomes of Borderline Resectable T3 in Locally Advanced Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Triplet Chemotherapy
    JUNYA KITADANI, KEIJI HAYATA, TARO GODA, SHINTA TOMINAGA, NAOKI FUKUDA, TOMOKI NAKAI, SHOTARO NAGANO and MANABU KAWAI
    Anticancer Research May 2025, 45 (5) 2225-2235; DOI: https://doi.org/10.21873/anticanres.17596
  • Open Access
    Recombinant Methioninase and Cisplatinum Act Synergistically to Inhibit Lewis Lung Carcinoma Cells But Not Normal Fibroblasts
    YOHEI ASANO, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, JIN SOO KIM, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, SEI MORINAGA, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    Anticancer Research May 2025, 45 (5) 1871-1876; DOI: https://doi.org/10.21873/anticanres.17566
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention

Visit the official website of Anticancer Research.
Back to top
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire